# Nolu reviews (2026): GLP-1 telehealth sellers | This GLP Every line came down a month apart, and every line is labeled per four weeks by the seller itself. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/nolu Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 All three fell, all per four weeks # Nolu review Every line came down a month apart, and every line is labeled per four weeks by the seller itself. ## The verdict Nolu publishes $199 per four weeks for injected semaglutide, $239 for the tablet and $279 for tirzepatide. Thirteen cycles a year make those $216, $259 and $302 a calendar month. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection · Oral Dose pricing Flat across doses Injection From $216/mo Oral From $259/mo Prescription Required Compounded Yes — not FDA-approved Nolu sells both molecules by injection and semaglutide as a tablet. Every line is priced against a four-week cycle rather than a calendar month, and the pricing page says so. 1. ## Who writes the prescription, and what do they see? A prescription precedes shipping. The pages state rates and cycles rather than describing who writes the prescription or how often a case is reviewed. Labeling the cycle honestly is the disclosure most sellers skip, and Nolu makes it on all three lines. The arithmetic is still left to the reader. 2. ## What happens when the dose goes up? The rates are recorded as flat across doses. A four-week cycle is the variable that moves instead, because thirteen of them arrive in a year rather than twelve. 3. ## What the price includes A year of injected semaglutide is $2,587 rather than the $2,388 twelve payments would suggest. The tablet is $3,107 and tirzepatide $3,627. All three figures fell — by $50, $40 and $60 — so any older quote is now high. 4. ## What it claims, and what it cites All three lines are compounded rather than manufactured. A pharmacy prepares them, and the FDA does not review a compounded preparation before dispensing. ## Where it holds up, and where it does not - Strength: The four-week cycle is labeled plainly - Strength: All three lines came down - Strength: Flat across doses on every line - Strength: A tablet route is priced separately - Limitation: Thirteen cycles a year, not twelve - Limitation: Each figure reads about 8% low - Limitation: No milligram published on any line - Limitation: The states served are not recorded ## What the evidence says about this kind of treatment The assessment above is about Nolu. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who counts cycles rather than months and wants a flat rate at any dose. Wrong for A reader comparing $199 against another seller's calendar-month figure. ## The evidence behind what Nolu prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Nolu compares | Seller | Who it suits | Go | | --- | --- | --- | | Roboclinic | Readers ready to commit a full year and wanting the discount that buys | | | SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | | | Try Ageless | Readers willing to price the same product twice before buying it once | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [NuviaRx](https://thisglp.com/reviews/nuviarx) [Obu Health](https://thisglp.com/reviews/obu-health) [Omnia TeleHealth](https://thisglp.com/reviews/omnia-telehealth) [Omzo](https://thisglp.com/reviews/omzo) [Ondra Health](https://thisglp.com/reviews/ondra-health) [Raeliva](https://thisglp.com/reviews/onlinesemaglutideorg) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked What does a calendar month cost? $216, $259 and $302 across the three lines, once thirteen cycles a year are counted. Did the prices change? All three fell a month apart, by $50, $40 and $60. Does a higher dose cost more? No. The rates are recorded as flat across doses. Is Nolu expensive compared with other GLP-1 telehealth sellers? Nolu publishes a starting figure of $216/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Nolu above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).